MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will report financial results for the first quarter ended March 31, 2026, and provide a business update before the market open. The announcement will be followed by a conference call and webcast for investors at 8:30am ET. Conference Details:Conference Date: Wednesday, May 13, 2026Conference Time: 8:30am ETConference Dial-in: 1-877-407-0792International Dial-in: 1-201-689-8263Conference ID: 13760062Webcast link: Click here.Participants can use Guest dial-in numbers above and be answered by an operator OR click the Call me™ link for instant telephone access to...

DALLAS, May 06, 2026 (GLOBE NEWSWIRE) — Westwood Holdings Group (WHG), a publicly-traded investment management boutique and wealth management firm, today announced monthly income distributions for Westwood Salient Enhanced Midstream Income ETF (NYSE: MDST), Westwood Salient Enhanced Energy Income ETF (NASDAQ: WEEI) and Westwood Enhanced Income Opportunity (YLDW) as shown in the table below. Part of the Westwood Income Series ETFs, these deliver income from both dividends and options premiums to help provide monthly income distributions for investors.ETF Ticker ETF Distribution per Share Annualized Distribution Rate1(NYSE:MDST) Westwood Salient Enhanced Midstream Income ETF 0.225  9.4%(NASDAQ:WEEI) Westwood Salient Enhanced Energy Income ETF 0.225 11.2%(NYSE: YLDW) Westwood Enhanced Income Opportunity 0.148 7.1%       MDST,...

HighlightsProgram Completion: A total of 962 metres were completed across four (4) reconnaissance drill holes at the Upper Prawn Lake, Southside, and Crab Lake target areas (Please see Figure 1). Anomalous Radioactivity: Multiple intervals of anomalous* radioactivity exceeding 300 counts per second (“cps”) were intersected in three (3) of the four (4) holes, totalling 1.5 metres of composite radioactivity. Geochemical assays are pending. Geophysical Correlation: The intersection of graphitic metasediments and associated sulphide mineralization in all four (4) holes validates the Project’s electromagnetic (“EM”) signatures and confirms the accuracy of the current geophysical model. Significant graphitic sequences are confirmed in ROC-26-001 (0-76 m) and ROC-26-003 (36-84 m), with graphitic fault gouge also present in ROC-26-004. Structural...

200µg Cohort Achieves 55% Complete Response at Day 57 Emerging as Registrational Grade Lead Regimen PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced results from a pre-specified expanded dataset analysis demonstrating positive dose response from its Phase 2 SKNJCT-003 study evaluating safety and efficacy of Doxorubicin Microneedle Array (D-MNA) to treat nodular basal cell carcinoma (BCC) of the skin, the most common type of skin cancer. These additional pre-specified analysis, build upon the previously reported positive topline results, provide expanded biological, histologic, and safety...

– The approval of Beyonttra in Brazil is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to date, including: – By Month 1, numerically fewer cumulative cardiovascular events, including CVM or recurrent CVH, were observed with acoramidis compared to placebo– A 42% reduction in composite ACM and recurrent CVH events relative to placebo at Month 30– A 50% reduction in the cumulative frequency of CVH events relative to placebo at Month 30 – Acoramidis is the first and only approved ATTR-CM treatment in the U.S., EU, UK, Switzerland, Japan, and Brazil that all have a label specifying near-complete stabilization (≥90%) PALO ALTO, Calif., May 06, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq:...

KUALA LUMPUR, Malaysia, May 06, 2026 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today officially announced the appointment of Tengku Dato’ Musahiddin Shah as an Independent Director, effective May 1, 2026, reinforcing the Company’s commitment to strengthening its leadership team and board composition as it continues to navigate the evolving market landscape. Over the years, Tengku Dato’ Musahiddin Shah has operated at the intersection of government, institutions, and the private sector, managing engagements requiring a high degree of discipline, discretion, and alignment among multiple stakeholders. Through his appointment, the Company is expected to benefit from his extensive experience in navigating government-related frameworks...

KELLOGG, Idaho and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to announce the appointment of Mark Child as an Independent Non-Executive Director to the Company’s board of directors (the “Board”), effective May 6, 2026. “I am delighted to welcome Mark Child to the Bunker Hill Board and as a member of its Corporate Governance & Nomination, Audit and Compensation Committees,” said Richard Williams, Executive Chairman. “His diverse capital markets and mining experience, plus his proven ability to create shareholder value in complex circumstances, will add much to our team and our governance system as we transition the Bunker Hill critical metals project from commissioning into sustainable, profitable operations,”  Mr....